Press Releases Choose Year All Items 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Search Press Releases Found 211 Results May 6, 2019 Minerva Neurosciences Reports First Quarter 2019 Financial Results and Business Updates April 29, 2019 Minerva Neurosciences to Report First Quarter 2019 Financial Results and Business Updates on May 6, 2019 April 11, 2019 Minerva Neurosciences Presents Pre-Clinical Data Suggesting a Mechanistic Role of Roluperidone in Addressing Negative Symptoms of Schizophrenia March 18, 2019 Minerva Neurosciences to Host Webcast Event on Schizophrenia March 12, 2019 Minerva Neurosciences Reports Fiscal 2018 Fourth Quarter and Year End Financial Results and Business Updates March 5, 2019 Minerva Neurosciences to Report Fiscal 2018 Fourth Quarter and Year End Financial Results and Business Updates on March 12, 2019 November 28, 2018 Minerva Neurosciences Announces New Patent Application for MIN-117 Related to Broad Effect on Pain November 21, 2018 Minerva Neurosciences to Present at Evercore ISI HealthCONx Conference on November 28, 2018 November 19, 2018 Minerva Neurosciences Announces Results of Dose Escalation Study Evaluating Roluperidone (MIN-101) Administered at Supra-Therapeutic Doses in Healthy Volunteers November 15, 2018 Minerva Neurosciences to Host Roluperidone Update and Key Opinion Leader Discussion of Negative Symptoms in CNS/Psychiatric Diseases on November 20, 2018 «...89101112...20...»